⌕
Eton Pharmaceuticals · ETON · Nasdaq
Tenet 47 · Mixed
Compare
$63.93+4.04%At closeTenet 47 · Mixed
$63.93+2.48 (+4.04%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Eton Pharmaceuticals (ETON) Stock

Eton Pharmaceuticals (ETON) closed at $63.93 on Nov 13, 2026; its Tenet Score is 47 of 100 against 313 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

10 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$63.93
Nov 13, 2026
Market cap
$1.8B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
42.6×
price ÷ earnings
52-week range
14.27 – 70.64
low → high · as of close, Nov 13, 2026
Tenet Score
47/100
Mixed · 313 Healthcare peers

Industry: Drugs

Eton Pharmaceuticals Inc scores 47/100. Mixed. Strongest on quality, value is the soft spot, trading at 43× earnings versus 313 Healthcare peers. Insufficient inputs: Tenet 47 is built from 3 of 4 pillars, from 85% of its inputs. Growth is left out because no growth rate could be measured.

Tenet Score · vs sector

n=313
47/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
19
Quality
73
Health
48
Growth
—

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Growth omitted — no data yet.
ValueFQualityBHealthDGrowth—MomentumA+
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
21.2×
price to book value
P/S
13.1×
price to fiscal 2025 sales
ROE
91%
return on equity
Operating margin
−1.1%
fiscal 2025, before interest and tax
Net margin
35.3%
of revenue kept
Current ratio
1.79
current assets to liabilities
Net debt / EBITDA
−0.7×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=313) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 70 US ETFs · top wrappers by weightSee all ETFs holding ETON →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Eton Pharmaceuticals in?

Eton Pharmaceuticals is in the Healthcare sector and the Drugs industry.

What is Eton Pharmaceuticals' Tenet Score?

Eton Pharmaceuticals' Tenet Score is 47 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.